Back to top

Lenz Therapeutics (LENZ) Sees Raised Price Target After FDA Approval

Lenz Therapeutics (LENZ) Sees Raised Price Target After FDA Approval

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

LENZ Therapeutics, Inc. (LENZ)